ACP
ADAP

Acuta Capital Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Acuta Capital Partners’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,165,000
Closed -$11.7M – 43
2020
Q2 		$11.7M Buy
+1,165,000
New +$11.7M 3.37% 9
2015
Q3 		– Sell
-30,000
Closed -$550K – 53
2015
Q2 		$550K Buy
+30,000
New +$550K 0.34% 43